The European Commission granted Marketing Authorisation for VUEWAY® (gadopiclenol ) for its use in pediatric patients under 2 years Bracco Imaging S.p.A., a global leader in diagnostic imaging, announces announces that on January 23, 2026, the European Commission (EC) granted the Marketing Authorisation for gadopiclenol in the European Union (EU) for pediatric patients below 2 years of age. 

The European Commission granted Marketing Authorisation for gadopiclenol for its use in pediatric patients under 2 years Bracco Imaging S.p.A., a global leader in diagnostic imaging, announces announces that on January 23, 2026, the European Commission (EC) granted the Marketing Authorisation for gadopiclenol in the European Union (EU) for pediatric patients below 2 years of age. 

Bracco Announces EU Launch of AiMIFY and Expands AI Portfolio At the 2026 European Congress of Radiology (ECR), Bracco Imaging S.p.A. today announced two major milestones in its AI & Digital Health strategy: the commercial launch in the European Union of AiMIFY® and a new strategic partnership with Avicenna.AI.